thiazoles has been researched along with sauvagine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciccocioppo, R; Cippitelli, A; Cramer, J; Gehlert, DR; Hamdouchi, C; Heilig, M; Hembre, EJ; Hipskind, PA; Lê, AD; Lu, J; McKinzie, D; Morin, M; Song, M; Thorsell, A | 1 |
| Cramer, J; Gehlert, DR; Morin, SM | 1 |
2 other study(ies) available for thiazoles and sauvagine
| Article | Year |
|---|---|
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.
Topics: Administration, Oral; Alcohol Drinking; Alcoholism; Amphibian Proteins; Animals; Anxiety; Behavior, Animal; Brain; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Male; Peptide Hormones; Peptides; Pituitary Gland; Pyridazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Administration; Stress, Physiological; Substance Withdrawal Syndrome; Thiazoles | 2007 |
Effects of corticotropin-releasing factor 1 receptor antagonism on the hypothalamic-pituitary-adrenal axis of rodents.
Topics: Adrenocorticotropic Hormone; Amphibian Proteins; Animals; Area Under Curve; Corticosterone; Hypothalamo-Hypophyseal System; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Peptide Hormones; Pituitary-Adrenal System; Pyridazines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Thiazoles | 2012 |